Subscribe
#32 Payal from .406 Ventures on Investing in Healthcare Technology

The Redox Podcast

#32 Payal from .406 Ventures on Investing in Healthcare Technology

November 24, 2020

#32 Payal from .406 Ventures on Investing in Healthcare Technology

On today’s show we have Payal Agrawal Divakaran. She leads digital health investments as a partner at .406 Ventures in Boston who was, of course, the first institutional investor to bet on Redox, leading our Series A back in October of 2015. We discuss some of her journey as well as where she’s making (and has made) bets in healthcare technology. This includes Redox, AristaMD, Heartbeat Health, WellbeHealth, and Axial. We also discuss areas where she has an active thesis and is looking for investments. 

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Proudly supported by:

cover
Hera Diagnostics is eradicating cervical cancer in developing communities Teo Tijerina is the CEO of Hera Medical Devices, a cancer diagnostics startup currently focusing on bringing a cervical cancer screening tool to market.